EW Q1 2025 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$50B

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.4B+6.2% YoY

Gross Profit

$1.1B78.7% margin

Operating Income

$395M27.9% margin

Net Income

$358M25.3% margin

EPS (Diluted)

$0.61

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

$280M

Free Cash Flow

$224M

Stock-Based Comp.

$40M

Balance Sheet

Total Assets

$13.0B

Total Liabilities

$2.8B

Stockholders' Equity

$10.1B

Cash & Equivalents

$3.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.4B	$1.3B	+6.2%
Gross Profit	$1.1B	$1.0B	+6.8%
Operating Income	$395M	$356M	+11.1%
Net Income	$358M	$352M	+1.7%

Revenue Segments

Transcatheter Heart Valves

$1.0B74%

Surgical Heart Valve Therapy

$251M18%

Transcatheter Mitral And Tricuspid Therapies

$115M8%

Geographic Segments

UNITED STATES

$839M59%

Europe

$342M24%

Rest of World

$150M11%

JAPAN

$82M6%